Hep B United/Tuberculosis Elimination Alliance Summit
“A Conversation with CDC Partners” Webinar
Thursday, January 20, 2022 | 11:00am HT / 1:00pm PT / 4:00pm ET
Hep B United and the Tuberculosis (TB) Elimination Alliance hosted “A Conversation with CDC Partners” webinar on January 20, 2022. Originally a part of the 2021 Hep B United / TB Elimination Alliance Summit, this webinar session was an opportunity to engage with leaders and partners from across the nation to discuss and collaborate on hepatitis B and TB elimination efforts.
Dr. Noele Nelson and Dr. Philip LoBue from the CDC discussed the challenges and opportunities to eliminate hepatitis B and TB and advance health equity.
Learning Objectives:
- Identify current trends with hepatitis B and TB;
- Learn about CDC center wide collaboration opportunities and joint priorities; and
- Learn about how COVID-19 has affected CDC’s priorities to eliminate hepatitis B and TB.
Intended Participants: Providers at community health organizations interested and/or invested in hepatitis B and/or TB/LTBI testing and treatment.
Fee: No cost/free
Moderator and Introductions
Joe Lee, MSHA, Director of Strategic Initiatives and Partnerships, Association of Asian Pacific Community Health Organizations
Kate Moraras, MPH, Deputy Director of Public Health, Hepatitis B Foundation and Director of Hep B United
Opening Remarks
Jonathan Mermin, MD, MPH, Director of the National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention
Jonathan Mermin, MD, MPH, is Director of the National Center for HIV, Viral Hepatitis, STD, and TB Prevention at CDC. Previously, he was Director of the Division of HIV/AIDS Prevention at CDC, Director of CDC-Kenya, and Director of CDC-Uganda. He has focused his public health career on science-based, practical programs that increase health equity and decrease incidence and mortality. Dr. Mermin was an internal medicine resident at San Francisco General Hospital, and a preventive medicine resident at CDC and the California Department of Health Services. He is a graduate of Harvard College and Stanford University School of Medicine, and received his MPH from Emory University. He is a Rear Admiral in the U.S. Public Health Service.
Featured Speakers
Noele P. Nelson, MD, PhD, MPH, Chief of Prevention Branch, Division of Viral Hepatitis, Centers for Disease Control and Prevention
Dr. Noele Nelson is a Pediatrician, and she holds a doctorate in Epidemiology. She joined the CDC/Division of Viral Hepatitis nine years ago and currently serves as the Chief of the Prevention Branch. In this role she oversees national efforts to test, implement and monitor hepatitis B and C care and cure cascades, perinatal hepatitis B and C prevention projects and viral hepatitis guideline development. Dr. Nelson focuses on hepatitis A and B vaccine research and policy and serves on the CDC Advisory Committee on Immunization Practices Steering Committee. She also has a strong interest in emergency response and has served on numerous CDC responses.
Philip LoBue, MD, FACP, FCCP, Director of Division of Tuberculosis Elimination, Centers for Disease Control and Prevention
Philip LoBue is the Director of the Division of Tuberculosis Elimination (DTBE) in CDC’s National Center for HIV, Viral Hepatitis, STD, and TB Prevention. Dr. LoBue received his undergraduate and medical degrees from the University of Pennsylvania. He received postgraduate training in Internal Medicine and Pulmonary and Critical Care Medicine at the University of California San Diego Medical Center where he was subsequently a Clinical Instructor and Assistant Clinical Professor of Medicine from 1995 to 1999. In 1999, Dr. LoBue joined DTBE as a medical epidemiologist assigned to the Tuberculosis Control Program in San Diego County, CA. In 2004, he moved to CDC headquarters in Atlanta, GA to become Chief of the Medical Consultation Team of DTBE. Between 2006 and 2014, Dr. LoBue was the Associate Director for Science for the division. Dr. LoBue is a fellow in the American College of Physicians and American College of Chest Physicians. He is also a member of the American Thoracic Society (ATS), in which he has served on the Ethics and Conflict of Interest Committee and the Program (chair 2008-2009), Planning, and Executive Committees of the Microbiology, Tuberculosis, and Pulmonary Infections Assembly. Dr. LoBue has authored or co-authored more the 80 publications including peer-reviewed journal articles, book chapters, and Morbidity and Mortality Weekly Report articles. He has chaired or served on more than 10 guidelines and recommendations committees and panels for multiple organizations including CDC, ATS, the US Federal Tuberculosis Task Force, and the World Health Organization. His scholarly interests include tuberculosis diagnosis, treatment, and transmission dynamics, evidence-based guideline development, and human subjects research ethics.
If you have any questions or need additional information, please contact us at 2021hbuteasummit@aapcho.org.
Webinar Resources
Additional Resources:
- Division of Viral Hepatitis Strategic Plan
- Viral Hepatitis Surveillance Report 2019 – Hepatitis B data
- Adult Vaccination Resources
- Strategies for Increasing Adult Vaccination Rates
- Reported Tuberculosis in the United States, 2020
- Latent TB Infection Resource Hub
- TB Centers of Excellence for Training, Education and Medical Consultation
- Tuberculosis Epidemiologic Studies Consortium (TBESC)
- Implementing an Electronic Directly Observed Therapy (eDOT) Program: A Toolkit for Tuberculosis (TB) Programs
- In-Person vs Electronic Directly Observed Therapy for Tuberculosis Treatment Adherence